Shinichi Ohkawa

Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study

Hideki Ueno, Tatsuya Ioka, Masafumi Ikeda et al. · Journal of Clinical Oncology · 2013 · 624 citations

Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study

Hedy L. Kindler, Tatsuya Ioka, D. J. Richel et al. · The Lancet Oncology · 2011 · 393 citations

Gemcitabine Versus Placebo, Oncology, Pancreatic Cancer +7

Phase <scp>II</scp> study of <scp>FOLFIRINOX</scp> for chemotherapy‐naïve Japanese patients with metastatic pancreatic cancer

Takuji Okusaka, Masafumi Ikeda, Akira Fukutomi et al. · Cancer Science · 2014 · 171 citations · Full text

A late phase II study of S-1 for metastatic pancreatic cancer

Takuji Okusaka, Akihiro Funakoshi, Junji Furuse et al. · Cancer Chemotherapy and Pharmacology · 2007 · 169 citations

Pancreatic Cancer, Gastrointestinal Oncology, Medicine +4

Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis

Kazuo Tarao, Yasushi Rino, Shinichi Ohkawa et al. · Cancer · 1999 · 158 citations · Full text